Cargando…
The Role of Biological and Small Molecule Therapy in the Management of Psoriatic Arthritis
The therapy of psoriatic arthritis (PsA) has blossomed in the past decade. Inhibition of tumor necrosis factor (TNF) has been at the fore of this approach and has paved the way for the investigation of many other potential pro-inflammatory and signaling pathways. Most of the initial studies of TNF i...
Autores principales: | Savage, Laura J., McGonagle, Dennis G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079095/ http://dx.doi.org/10.1007/s13554-013-0010-0 |
Ejemplares similares
-
Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015) -
Integrating imaging and biomarker assessment to better define psoriatic arthritis and predict response to biologic therapy
por: Elliott, Ashley, et al.
Publicado: (2021) -
Defining Pre-Clinical Psoriatic Arthritis in an Integrated Dermato-Rheumatology Environment
por: Savage, Laura, et al.
Publicado: (2020) -
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
por: Zabotti, Alen, et al.
Publicado: (2020) -
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)